Will there be an Emergency Use Authorization (EUA) granted for a COVID-19 vaccine before 2021?

This market is on if there will be an Emergency Use Authorization (EUA) granted for a COVID-19 vaccine before January 1st, 2021. “The Emergency Use Authorization (EUA) authority allows FDA to help strengthen the nation’s public health protections against CBRN threats by facilitating the availability and use of MCMs needed during public health emergencies.“ The market will resolve to “Yes“ if an EUA is granted for a COVID-19 vaccine, according to this link: [https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covid19euas](https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covid19euas), before January 1st, 2021. Even if the vaccine is not widely distributed by that date, if an EUA is granted, the market will resolve to “Yes“. If no EUA is granted for a COVID-19 vaccine by January 1st, 2021, the market will resolve “No”. Note, this market is only for vaccines, not general treatment. The market will be resolved in good faith at the sole discretion of the Markets Integrity Committee (MIC).